(Q34638198)

3 August 2017

title

Clostridium difficile: epidemiology, pathogenesis, management, and prevention of a recalcitrant healthcare-associated pathogen (English)

1 reference

3 August 2017

main subject

Clostridium difficile

0 references

3

Mary Beth Graham

1 reference

3 August 2017

Victor O Badger

1

1 reference

3 August 2017

Nate A Ledeboer

series ordinal

2

1 reference

3 August 2017

Charles E Edmiston

series ordinal

4

1 reference

3 August 2017

publication date

10 May 2012

1 reference

Journal of Parenteral and Enteral Nutrition

3 August 2017

published in

1 reference

3 August 2017

volume

36

1 reference

3 August 2017

issue

6

1 reference

3 August 2017

page(s)

645-662

1 reference

Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Clostridium difficile 30 years on: what has, or has not, changed and why?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Fatal membranous staphylococcal enteritis in surgical patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Pseudomembranous colitis: Presence of clostridial toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Clostridium difficile and the aetiology of pseudomembranous colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Diversity of the human intestinal microbial flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Clostridium difficile PCR ribotypes in calves, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Clostridium difficile and the disease it causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

The ecology and pathobiology of Clostridium difficile infections: an interdisciplinary challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Treatment of Clostridium difficile-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

The role of toxin A and toxin B in the virulence of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Biology of Clostridium difficile: implications for epidemiology and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Structure and mode of action of clostridial glucosylating toxins: the ABCD model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Identification of Clostridium difficile toxin B cardiotoxicity using a zebrafish embryo model of intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Clostridium difficile colitis causing toxic megacolon, severe sepsis and multiple organ dysfunction syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Toxin B is essential for virulence of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Epidemiology and control of Clostridium difficile infections in healthcare settings: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Molecular and microbiological characterization of Clostridium difficile isolates from single, relapse, and reinfection cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Surface layers of Clostridium difficile endospores

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Epidemiology of Clostridium difficile-associated infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

The changing epidemiology of Clostridium difficile infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Clostridium difficile infection in older adults: a review and update on its management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Clostridium difficile associated infection, diarrhea and colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Risk factors for Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Clostridium difficile infection: clinical spectrum and approach to management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Clostridium difficile infection: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Incidence of Clostridium difficile infection in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Fatal Clostridium difficile enteritis after total abdominal colectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Clostridium difficile enteritis: an early postoperative complication in inflammatory bowel disease patients after colectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Clostridium difficile infection--an unusual cause of refractory pouchitis: report of a case

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Clostridium difficile infection in patients with ileal pouch-anal anastomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile Infection: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Clostridium difficile testing algorithms: what is practical and feasible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Clinical usefulness of components of the Triage immunoassay, enzyme immunoassay for toxins A and B, and cytotoxin B tissue culture assay for the diagnosis of Clostridium difficile diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

A two-stage algorithm for Clostridium difficile including PCR: can we replace the toxin EIA?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Tests for the diagnosis of Clostridium difficile infection: the next generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Rapid and reliable diagnostic algorithm for detection of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Multicenter evaluation of a new screening test that detects Clostridium difficile in fecal specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Diagnosis and monitoring of Clostridium difficile infections with the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Detection of toxigenic Clostridium difficile in pediatric stool samples: an evaluation of Quik Check Complete Antigen assay, BD GeneOhm Cdiff PCR, and ProGastro Cd PCR assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Evaluation of a new commercial TaqMan PCR assay for direct detection of the clostridium difficile toxin B gene in clinical stool specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Prospective evaluation of the Meridian Illumigene™ loop-mediated amplification assay and the Gen Probe ProGastro™ Cd polymerase chain reaction assay for the direct detection of toxigenic Clostridium difficile from fecal samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Impact of PCR testing for Clostridium difficile on incident rates and potential on public reporting: is the playing field level?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Alternative treatments for Clostridium difficile disease: what really works?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Rifaximin for the treatment of recurrent Clostridium difficile infection after liver transplantation: A case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Rifaximin in treatment of recurrent Clostridium difficile-associated diarrhea: an uncontrolled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Fidaxomicin versus vancomycin for Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Tigecycline for the treatment of severe Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Comparative effectiveness of Clostridium difficile treatments: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Probiotics for treatment of Clostridium difficile-associated colitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Systematic review and meta-analysis of Saccharomyces boulardii in adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Intravenous immunoglobulin for the treatment of Clostridium difficile infection: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

The role of immunoglobulin for the treatment of Clostridium difficile infection: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Treatment with monoclonal antibodies against Clostridium difficile toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Measures to control and prevent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHEA/APIC/IDSA Hand Hygiene Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Environmental contamination makes an important contribution to hospital infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Implementing automated surveillance for tracking Clostridium difficile infection at multiple healthcare facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

Clostridium difficile: a new zoonotic agent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607112446703

21 January 2018

Identifiers

DOI

10.1177/0148607112446703

1 reference

3 August 2017

1 reference